Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Fresenius Medical Care AG (FMS) over the last 16 years, with Q3 2025 value amounting to -$88.7 million.

  • Fresenius Medical Care AG's Gains from Investment Securities rose 1792.1% to -$88.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$318.6 million, marking a year-over-year increase of 3692.83%. This contributed to the annual value of $188.1 million for FY2020, which is 3308.27% down from last year.
  • According to the latest figures from Q3 2025, Fresenius Medical Care AG's Gains from Investment Securities is -$88.7 million, which was up 1792.1% from -$87.5 million recorded in Q2 2025.
  • Fresenius Medical Care AG's 5-year Gains from Investment Securities high stood at -$21.5 million for Q1 2024, and its period low was -$231.8 million during Q2 2024.
  • Over the past 5 years, Fresenius Medical Care AG's median Gains from Investment Securities value was -$87.5 million (recorded in 2025), while the average stood at -$97.0 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first plummeted by 29658.87% in 2023, then soared by 6226.67% in 2025.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Gains from Investment Securities stood at -$68.6 million in 2021, then surged by 47.18% to -$36.3 million in 2022, then crashed by 296.59% to -$143.8 million in 2023, then grew by 24.88% to -$108.0 million in 2024, then rose by 17.92% to -$88.7 million in 2025.
  • Its Gains from Investment Securities stands at -$88.7 million for Q3 2025, versus -$87.5 million for Q2 2025 and -$34.5 million for Q1 2025.